Skip to content

Clinical trials

Completed Major Depressive Disorder trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Status: Completed Country / region: Japan Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20083
20093
20104
20117
20123
20132
20141
20151
20172
20182
20203
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Co., Ltd.6
Takeda6
Eli Lilly and Company5
Astellas Pharma Inc3
Boehringer Ingelheim3
GlaxoSmithKline2
Nagoya City University2
Pfizer2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder38
Depressive Disorder2
Depressive Disorder, Treatment-Resistant1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.